Author: Eric Franco

What every section of ISO 13485:2016 actually requires — and where auditors dig deepest

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

The Standard Reads Like a Checklist. It Isn’t One.

ISO 13485:2016 has eight clauses. Five of them carry actual requirements. That structure looks simple on the page — and it’s exactly why so many quality teams underestimate how much interpretation each clause demands once an auditor starts asking “show me.” This ISO 13485 clauses explained guide breaks down what each section requires, where the requirements overlap, and what auditors and FDA investigators may look for.

The FDA’s Quality Management System Regulation (QMSR) took effect February 2, 2026, incorporating ISO 13485:2016 by reference into 21 CFR Part 820. That changes what this clause structure means in practice. FDA also replaced its inspection methodology the same day — the Quality System Inspection Technique (QSIT) is gone, replaced by Compliance Program 7382.850. Getting the clause boundaries right now has a direct line to how an FDA investigator scopes an inspection, not just how a certification body audits.

Regulatory affairs and quality professionals reading this already know ISO 13485 exists. What’s harder to find is a breakdown that goes past the clause titles and into what each section demands in practice — where the audit findings cluster, where risk management threads through clauses that don’t mention risk in their title, and where the standard’s lack of an Annex SL high-level structure changes how it should be read compared to ISO 9001.

My perspective on this comes from 25+ years in operations leadership, an ISO 9001 Internal Auditor certification, and a Six Sigma Green Belt — a lot of that time spent on both sides of the table, building QMS documentation and sitting in CAPA reviews when a gap in that documentation turned into a finding. The pattern holds across every regulated QMS I’ve worked with: teams don’t fail because they misread a clause. They fail because they treated clause boundaries as more rigid than the standard actually intends, and missed how much cross-referencing an auditor expects between clauses 4 through 8.

In This Guide

• How ISO 13485:2016 is structured, and why it doesn’t follow ISO’s Annex SL format
• A clause-by-clause breakdown of Clauses 4 through 8
• How FDA’s current inspection program, Compliance Program 7382.850, reorganizes inspections around six QMS Areas
• The most common audit findings tied to specific sub-clauses
• Where risk management actually appears throughout the standard
• How ISO 13485 clause numbering compares to ISO 9001
• FAQs on structure, exclusions, and transition timing

👉 Start Here (Top Resources)

• Buying the standard: Get the official ISO 13485:2016 text through ANSI Webstore — the authorized source, with international-language editions available for teams managing multi-region QMS documentation.
• Training: ISO 13485 training through BSI Group — useful if your internal auditors need clause-level training before your next surveillance cycle.
• Related standard: ISO 14971:2019 (risk management) — clause 7.1 of ISO 13485 leans directly on this standard, so most teams end up buying both.

ISO 13485 Clauses Explained: How the Standard Is Structured

ISO 13485:2016 is built around eight clauses. The first three are introductory — they define scope, point to normative references, and set terminology. They carry no auditable requirements on their own, but skipping them is a mistake most teams make once and then correct the hard way.

Clauses 4 through 8 are where the requirements live. This is the part of the standard your certification body actually audits against, clause by clause, sub-clause by sub-clause.

Here’s something worth knowing before you go further: ISO 13485 does not follow the Annex SL high-level structure that ISO 9001:2015, ISO 14001, and ISO 45001 all share. Those three standards align clause-for-clause at the top level, which is why integrated management systems work so cleanly across them. ISO 13485 kept its own structure when it was revised in 2016, specifically so it could stay independent of ISO 9001 revision cycles — a deliberate choice by the technical committee to protect regulatory stability for device manufacturers. If you’re coming from an ISO 9001 background, this is the first adjustment to make: don’t assume clause 7 means the same thing in both standards. It doesn’t.

Clauses 1 Through 3: No Requirements, But Don’t Skip Them

Clause 1 (Scope) defines what the standard covers and, critically, how exclusion and non-application work. ISO 13485 doesn’t let an organization simply skip a requirement that seems inconvenient — where a clause is excluded or considered non-applicable (say, you don’t perform installation), the scope and justification have to be documented in the quality manual under Clause 4.2.2, and be prepared to defend that justification during an audit.

Clause 2 (Normative References) points to ISO 9000:2015 for terms and definitions. You don’t need to buy ISO 9000 to comply, but auditors do expect your team to be using its vocabulary consistently — “nonconformity,” “corrective action,” and “verification” all carry specific meanings your documentation should match.

Clause 3 (Terms and Definitions) establishes the vocabulary used throughout the standard, including specific definitions for concepts like medical device, complaint, risk, and post-market surveillance. Getting comfortable with this terminology matters more than it looks like it should — auditors expect your documentation to use these terms precisely, not colloquially.

📥 Before diving into clauses 4-8: if your QMS documentation predates 2020, run it against the current ISO 13485 Documentation Requirements breakdown first. Most gaps trace back to documentation structure, not missing procedures.

Clause 4: Quality Management System

Clause 4 sets the general requirements for the QMS itself — and it’s where most audit programs start, because everything downstream depends on it.

4.1 General Requirements requires you to identify your QMS processes, map their sequence and interaction, and — this is the part that trips up contract manufacturers — maintain control over any process you outsource. Most common finding: outsourced processes (contract sterilization, contract testing, third-party calibration) that exist operationally but were never formally brought into QMS scope. If a supplier touches your product or your data, your QMS has to account for it.

4.2 Documentation Requirements covers the quality manual, the Medical Device File (Clause 4.2.3), document control, and record control. This requirement is specific to this standard — it’s not something ISO 9001 asks for. It’s a defined set of documents and references demonstrating a device meets its requirements throughout its lifecycle, and auditors will ask to see it assembled, not scattered across a dozen disconnected folders.

If your documentation still uses FDA’s old terminology, this is worth getting precise about. As of February 2, 2026, the terms Device Master Record, Device History Record, and Design History File no longer appear in 21 CFR Part 820. Those legacy record concepts weren’t simply eliminated; their applicable requirements are now addressed through the QMSR framework and ISO 13485’s own structure. Most of what a Device Master Record covered lives in the Medical Device File at Clause 4.2.3, while the Design History File corresponds to the Design and Development File at Clause 7.3.10. These aren’t simple one-for-one renamings: the Medical Device File in particular is a broader requirement than the DMR it replaced, so a straight terminology swap in your documentation will likely leave gaps a crosswalk exercise would catch.

Sub-clause 4.2.4 (control of documentation) and 4.2.5 (control of records) get their own scrutiny. Auditors typically check three things here: are documents reviewed and approved before use, is there a mechanism to prevent use of outdated versions, and are records retained for a defined, justified period. If you’re preparing for your first audit under this clause → build your document control procedure before you build anything else. Everything else in the QMS references it.

Clause 5: Management Responsibility

Clause 5 puts specific, named accountability on top management — not “the quality department,” but leadership itself.

This clause requires a documented quality policy, measurable quality objectives, evidence of planning for QMS changes, and a sub-clause I’ve seen come up repeatedly in audit findings — management review. Clause 5.6.2 is unusually prescriptive for an ISO standard: it names twelve required inputs, and a compliant management review record has to address all of them or document why one doesn’t apply — feedback, complaint handling, reporting to regulatory authorities, audits, monitoring and measurement of processes, monitoring and measurement of product, corrective action, preventive action, follow-up actions from previous reviews, changes that could affect the QMS, recommendations for improvement, and applicable new or revised regulatory requirements. A management review that skips several of these, or that doesn’t produce documented outputs and action items, is a finding waiting to happen — and under the current FDA inspection framework, it’s no longer just a certification-audit concern (more on that below).

If you are already ISO 9001 certified, this clause will feel familiar structurally — but ISO 13485 expects a tighter link between management review and regulatory requirements specifically, not just general business objectives.

Clause 6: Resource Management

Clause 6 covers human resources, infrastructure, and work environment — including contamination-control requirements under 6.4.2 that go considerably further than ISO 9001’s general treatment of work environment.

6.2 Human Resources requires documented competence for anyone whose work affects product quality — not just “trained,” but competence tied to education, skills, and experience, with evidence. 6.3 Infrastructure requires maintenance records for equipment critical to product conformity. 6.4 Work Environment and Contamination Control is where device manufacturers doing anything sterile, implantable, or otherwise contamination-sensitive get the most detailed scrutiny — cleanroom classifications, gowning procedures, and environmental monitoring data all trace back here.

Clause 7: Product Realization

Clause 7 is the largest clause in the standard, and it’s where design controls, purchasing, production, and servicing all live.

7.1 Planning of Product Realization is where ISO 13485 explicitly requires documented risk management processes within product realization, with records maintained throughout. The clause’s note points readers to ISO 14971 for further guidance on structuring that risk management activity — it’s a reference, not a formal incorporation, though in practice most organizations end up using ISO 14971’s framework to satisfy this requirement.

7.3 Design and Development is one of the sub-clauses most commonly identified as non-applicable by contract manufacturers who don’t design product — but where it applies, it can’t be excluded lightly, and the justification has to hold up to the same Clause 4.2.2 scrutiny as any other exclusion. If it applies to you, this is the densest technical section of the standard: design inputs, outputs, review, verification, validation, transfer, and change control, each with its own documented evidence trail. Most common finding: design changes made without running them back through the full verification/validation cycle, especially late in development when schedule pressure is highest.

7.4 Purchasing requires supplier evaluation criteria proportionate to risk, and re-evaluation triggers when supplier performance changes. 7.5 Production and Service Provision covers process validation for anything that can’t be fully verified by downstream inspection — sterilization is the textbook example, which is why it gets its own dedicated body of standards. 7.6 Control of Monitoring and Measuring Equipment ties directly into your calibration program.

If you are under customer or FDA pressure to show design control maturity quickly → prioritize closing out 7.3 documentation gaps before anything else in this clause. In my experience, it’s one of the first sections a regulatory reviewer or auditor asks to see in depth.

Clause 8: Measurement, Analysis and Improvement

Clause 8 is where the QMS proves it’s actually working — and where CAPA lives.

8.2 Monitoring and Measurement covers feedback, complaint handling, and internal audit. Complaint handling under this clause has to interface with FDA’s separate adverse-event reporting requirements — a complaint that may represent a reportable event under Medical Device Reporting (21 CFR Part 803) can’t remain solely an internal QMS record; it has to be evaluated independently against those reporting obligations.

8.3 Control of Nonconforming Product requires documented procedures for identifying, segregating, and dispositioning nonconforming product, including for product discovered nonconforming after delivery — which is where recall-adjacent procedures connect back into the standard.

8.5 Improvement is where corrective and preventive action requirements sit. CAPA under ISO 13485 requires root cause investigation, verification that the action taken was effective, and — a detail I’ve seen auditors check for specifically — evidence that you evaluated whether the same nonconformity could exist elsewhere in the organization before closing the CAPA. A CAPA record that fixes one instance without documenting that broader check is incomplete by this clause’s own standard, regardless of whether the immediate fix worked.

For a deeper breakdown of this clause specifically, see our full guide to CAPA requirements in ISO 13485.

Where ISO 13485 and FDA’s QMSR Overlap by Clause

FDA’s Quality Management System Regulation took effect February 2, 2026, incorporating ISO 13485:2016 by reference into 21 CFR Part 820. That’s the headline most coverage stopped at. What matters more for how you prepare is what happened on the inspection side the same day: FDA retired the Quality System Inspection Technique (QSIT), the inspection methodology it had used since 1999, and replaced it with a new compliance program manual — CP 7382.850, Inspection of Medical Device Manufacturers.

QSIT organized inspections around four subsystems. CP 7382.850 reorganizes them around six QMS Areas, each mapped to ISO 13485 clauses with FDA-specific requirements layered in:

• Management Oversight — the QMS itself, management review, the medical device file, and product realization planning
• Design and Development — design inputs, outputs, review, verification, validation, software validation, and transfer
• Production and Service Provision — production planning, process validation, and servicing
• Measurement, Analysis, and Improvement — complaint handling, feedback, internal audits, corrective and preventive action, and control of nonconforming product
• Outsourcing and Purchasing — supplier evaluation and control
• Change Control — how changes to product or process are managed and documented

Alongside the six QMS Areas, inspections also evaluate four Other Applicable FDA Requirements (OAFRs) that sit outside ISO 13485’s text entirely: Medical Device Reporting (21 CFR Part 803), Corrections and Removals reporting (21 CFR Part 806), Medical Device Tracking (21 CFR Part 821), and Unique Device Identification (21 CFR Part 830). This is where the clause structure above stops covering everything — these four areas are FDA-specific regulatory obligations, not ISO 13485 requirements. They’re evaluated during routine surveillance, compliance follow-up, and PMA postmarket inspections; a narrow exception can apply to certain PMA preapproval inspections when the manufacturer hasn’t yet introduced the device to the U.S. market.

The change that affects Clause 5 most directly: under the prior QSR, management review records were categorically exempt from FDA review under §820.180(c). Under CP 7382.850, that exemption is gone. Management review now sits squarely inside the Management Oversight QMS Area, and an investigator can ask to see it — which means the twelve required Clause 5.6.2 inputs covered above aren’t just a certification-audit concern anymore.

One caution worth stating plainly: ISO 13485 certification and FDA QMSR compliance are related but not identical. A QMS built cleanly against Clauses 4 through 8 covers the ISO 13485 core that QMSR incorporates, but it doesn’t automatically satisfy the four OAFRs — those require their own documented processes regardless of how strong your clause-by-clause QMS is.

If you’re not sure whether your current documentation satisfies both frameworks → our FDA QSR vs ISO 13485 comparison and MDSAP vs ISO 13485 breakdown both walk through this in more detail than fits here.

ISO 13485 vs ISO 9001: Same Numbers, Different Weight

The clause numbers look similar enough to cause real confusion — both standards use “Clause 7” for a large operational section, but the content underneath diverges substantially. If your organization holds both certifications, don’t assume a clause 7 audit finding under one standard tells you anything about your standing under the other. For the full comparison, see ISO 9001 vs ISO 13485.

The objection I hear most on this topic: “We’re already ISO 9001 certified — how much of this is actually new work?” Realistically, expect Clauses 5 and 6 to require the least rework, since management responsibility and resource management overlap heavily in intent. Clauses 4, 7, and 8 are where the medical device-specific requirements add real documentation and process work — the medical device file, design control rigor, and CAPA’s broader-impact evaluation aren’t things a general ISO 9001 QMS already has built in.

Most teams don’t fail an ISO 13485 audit because they misunderstood a clause. They fail because they assumed a documented procedure was enough without checking whether it actually produces the evidence an auditor will ask to see.

👉 Run a structured check before that assumption gets tested in front of an auditor → ISO 13485 Gap Assessment Checklist

Quick Clause Reference Checklist

A clause tells you what’s required. It doesn’t tell you what to hand an auditor when they ask for proof. Below is a quick translation — clause by clause, requirement to evidence.

✅ Clause 4 — QMS scope defined, outsourced processes controlled, medical device file assembled
✅ Clause 5 — Quality policy documented, management review covering all required inputs
✅ Clause 6 — Competence records current, contamination controls documented where applicable
✅ Clause 7 — Risk management documented within product realization; ISO 14971 provides further guidance; design control records complete, supplier evaluation criteria defined
✅ Clause 8 — Complaint handling tied to regulatory reporting, CAPA records show broader-impact evaluation

⚠️ Clauses 1–3 — Exclusions and non-applicability justified in the quality manual, not just left blank

For implementation sequencing beyond the checklist above, our ISO 13485 Implementation Roadmap and ISO 13485 Gap Assessment: Step-by-Step Guide walk through the order to tackle these in.

FAQ

Not Sure What to Do Next?

🔹 Still researching how the clauses fit together? Start with What Is ISO 13485? for the foundational overview before working through this clause breakdown a second time.

🔹 Ready to assess where your QMS actually stands? Run the ISO 13485 Gap Assessment Checklist against the clause list above — it’s built to map directly to Clauses 4 through 8.

🔹 Need the official standard text to cite exact clause language? Purchase ISO 13485:2016 through ANSI Webstore — use code CC2026 for 5% off through December 31, 2026. International-language editions are available for teams managing documentation across multiple regulatory regions.

🔹 Need your internal auditors trained on this clause structure before your next surveillance audit? ISO 13485 training through BSI Group covers the structure clause by clause with a certification body’s own instructors.

The Standards Navigator breaks down what these clauses actually demand — not just what they’re titled — so your team can walk into an audit knowing which sub-clause the finding will land on before it does.

Stay Ahead of Clause-Level Changes

Most QMS documentation doesn’t fail because a team ignored ISO 13485. It fails because someone mapped a procedure to the wrong clause once, early on, and every review since has confirmed the wrong thing.

Organizations that treat the clause structure above as a living reference — checked against actual audit findings, updated as FDA’s QMSR enforcement approach becomes clearer — walk into surveillance audits with far fewer surprises than organizations treating their quality manual as a document they wrote once and filed away.

The Standards Navigator tracks ISO 13485, QMSR, and the surrounding medical device standards landscape as they develop, not just at certification time.

👉 Get updates on ISO 13485 and medical device QMS requirements
👉 Be first to access new gap assessment tools and clause-mapping resources

Industrial Compliance. Clearly Explained.